Facebook Linkedin RSS Twitter Youtube
Home 2018

Merck KGaA

Stanford Spinout Partners with Merck KGaA, Genentech in Cancer Studies of Hu5F9-G4
Cancer

Stanford Spinout Partners with Merck KGaA, Genentech in Cancer Studies of Hu5F9-G4

MilliporeSigma Opens Burlington, MA, Campus
Drug Discovery

MilliporeSigma Opens Burlington, MA, Campus

Merck KGaA Plans €35M Expansion of Italian Manufacturing Site
Industry News

Merck KGaA Plans €35M Expansion of Italian Manufacturing Site

Obesity, Wasting Syndrome Both Wired into Hormonal Emergency Circuit
Cancer

Obesity, Wasting Syndrome Both Wired into Hormonal Emergency Circuit

MilliporeSigma to Acquire Natrix Separations
Bioprocessing

MilliporeSigma to Acquire Natrix Separations

Merck KGaA, Sigma-Aldrich Accused of Misleading EU on Merger
Industry News

Merck KGaA, Sigma-Aldrich Accused of Misleading EU on Merger

eFFECTOR, Pfizer, Merck KGaA Partner to Combine Avelumab with MNK1/2 Inhibitor
Cancer

eFFECTOR, Pfizer, Merck KGaA Partner to Combine Avelumab with MNK1/2 Inhibitor

Merck, Aduro Expand Collaboration to Combine LADD Cancer Therapy with Keytruda
Drug Discovery

Merck, Aduro Expand Collaboration to Combine LADD Cancer Therapy with Keytruda

EpiThany, Merck KGaA, Pfizer Agree to Trial with Cancer Vaccine–Avelumab Combo
Cancer

EpiThany, Merck KGaA, Pfizer Agree to Trial with Cancer Vaccine–Avelumab Combo

Merck KGaA, Pfizer PD-L1 mAb Wins Accelerated FDA Nod for Urothelial Carcinoma
Drug Discovery

Merck KGaA, Pfizer PD-L1 mAb Wins Accelerated FDA Nod for Urothelial Carcinoma

1234...13Page 3 of 13
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.